Le Lézard
Classified in: Health
Subject: ACC

ZINZINO AB (PUBL): Zinzino now seeks acquisitions in the US and Asia to increase distribution power


GOTHENBURG, Sweden, June 7, 2024 /PRNewswire/ -- Zinzino, a global direct sales company from Scandinavia pioneering personalized nutrition and preventative health, is actively pursuing acquisitions across the US and Asia to enhance their business strategy for sustainable, profitable growth.

CEO Dag Bergheim Pettersen reveals that their primary targets of interest are focused on increased distribution power, with product portfolios within dietary supplements being an added bonus.

The United States accounts for Zinzino's third largest market share today and is also the leading direct sales market in the world, two decisive factors for why Zinzino is now actively looking to gain more traction in the US. Dag Bergheim Pettersen and his team have not set any specific geographic preferences within the US and are scouting targets on their own, drawing on their large network of contacts without taking financial advice to conduct the search. Dag Bergheim Pettersen does his own M&A advisory, with the aid of external lawyers and accountants on a deal-by-deal basis.

Zinzino typically finances its' acquisitions via a combination of upfront and earnout payments, often paying in cash and shares. Dag Bergheim Pettersen explains that the size of potential acquisitions depends on the deal structure. In May of this year, Zinzino announced the acquisition of assets from the Luxembourg-based, direct sales company Xelliss at a fixed purchase price of EUR 2M, with a conditional additional purchase price of up to EUR 8M.

Similarly, Zinzino acquired the Swiss based direct sales company Enhanzz in the spring of 2022, which is now an innovative force driving the DACH region.

Pioneering test-based nutrition

Zinzino is a global health tech company aiming to become a world leader in preventative health by offering individualized solutions to combat lifestyle-related conditions. The company's extensive product portfolio includes a range of omega, immune, restore, and gut health supplements scientifically proven to help balance, restore and support the body. It also features a biotech skincare range and weight management products. To ensure the supplements are tailored to individual needs, Zinzino offers three different home health tests for personal fatty acid profiling, current vitamin D and long-term blood sugar levels combined with a lifestyle assessment. The blood sample analysis is performed in strict confidentiality by the world leader in dried blood spot testing, independently managed to guarantee accurate and unbiased results. Zinzino's in-house scientists and nutritional experts then review the individual results before offering tailored recommendations on how to reach personal health goals with healthy habits, exercise and supplementation.

CEO Dag Bergheim Pettersen explains that Zinzino is currently present in 47 markets globally and the products are shipped to more than 100 countries worldwide.

Zinzino is listed on Nasdaq First North Premier Growth Market with a market cap of SEK 2.7bn (EUR 230m). The company reported a total revenue of SEK 1.8bn with an operating profit of SEK 209m in 2023, up from total revenue of SEK 1.4bn with an operating profit of SEK 87m in 2022.

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

Pictures for publication free of charge:

[email protected]

Certified Adviser: Carnegie Investment Bank AB (publ)

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/zinzino/r/zinzino-ab--publ--zinzino-now-seeks-acquisitions-in-the-us-and-asia-to-increase-distribution-power,c3996796

The following files are available for download:

https://mb.cision.com/Public/10976/3996796/81333321c1bbd42c.pdf

Press release Zinzino seeks acquisitions in US June 2024

 


These press releases may also interest you

at 06:00
The report "Anti-Migrating Agent Market by Type (Non-ionic, Anionic, Cationic, Amphoteric), Grades (Technical, Food, Pharmaceutical), Application, Chemistry (Organic, Inorganic), End-Use Industry (Textile, Plastics, Paper), and Region - Global...

at 05:42
Gupshup, the world's leading Conversation Cloud, in collaboration with Meta, the Sudan Medical Specialization Board and non-profit Shabaka today announced the launch of a telemedicine chatbot providing healthcare access for Sudanese refugees in...

at 05:23
The revenue in June for Zinzino's sales markets increased by 13% and amounted to SEK 148.5 (131.4) million. Faun Pharma's external sales decreased and amounted to SEK 5.8 (8.5) million. Overall, the Group increased revenues by 10% to SEK 154.3...

at 05:00
The global Specialty Enzymes Market size is estimated to be valued at USD 6.1 billion in 2024 and is projected to reach USD 9.2 billion by 2029, recording a CAGR of 8.5% from 2024 to 2029 according to a report published by MarketsandMarketstm. The...

at 05:00
Kvantify, a leading quantum software start-up, has announced the successful closure of a EUR 10 million seed round. This funding will enable Kvantify to strengthen its position as a global leader in quantum computing, with an initial focus on...

at 04:37
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cytotoxic Drugs and HPAPI Manufacturing  Market- (Type of Product (HPAPI and highly potent finished dosage form), Company Size (Small, Mid-sized, Large,...



News published on and distributed by: